Advertisement
News
Advertisement

Abstracts for the EORTC-NCI-AACR Symposium in Berlin go up online on Friday, Oct. 29

Wed, 10/27/2010 - 3:31pm
EurekAlert

The majority of the abstracts to be presented at the EORTC-NCI-AACR [1] Symposium on "Molecular targets and cancer therapeutics" will go up online two weeks before the meeting at 00.01 hrs CET on Friday 29 October. The Symposium takes place in Berlin on 16-19 November.

Journalists are free to report on the online abstracts from the time that they go up online before the Symposium; however, they should bear in mind that all the abstracts had to be submitted by 15 June, and by the time the research will be presented to the Symposium in November some of the data and results may have changed.

Some abstracts, including late breaking abstracts and those that form part of the media programme, are not being published online before the Symposium begins. They will be published in a supplement abstract book available at the Symposium and will be posted online on the day of their presentation to the meeting; they will be embargoed to 00.01 hrs (CET) on those days.

The online abstracts can be found at: http://www.ecco-org.eu/Conferences-and-Events/EORTC-NCI-AACR-2010/Abstracts-online/page.aspx/2528

This Symposium, organised jointly by the European Organisation for the Research and Treatment of Cancer, the US National Cancer Institute and the American Association for Cancer Research, offers the media:

  • Cutting edge information on new cancer drug research and development from experts in Europe, North America, Asia and Australia;
  • Free registration for bona fide media with official press credentials (press card and/or a commissioning letter on headed paper from the editor of the journal/website they represent);
  • All sessions open to journalists;
  • Media centre with free computing, international phones, and internet.

Around 2,200 international experts in cancer research will present and discuss recent advances in the early development of promising new compounds in different stages of pre-clinical and clinical research.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading